Skip to main content
. 2021 Oct 4;8:742360. doi: 10.3389/fsurg.2021.742360

Figure 12.

Figure 12

Validation of the risk score prognostic model among the different clinical groups. (A) Age ≤65; (B) age >65; (C) T1-2; (D) T3-4; (E) N0; (F) N1–3; (G) stage I–II; (H) stage III–IV. The blue lines represent the low-risk groups, the red lines represent the high-risk groups.